Imaging agent to highlight brain tumours before surgery
Part of Cancer clinical trials.
This study uses a special imaging agent (called PSMA) that may help doctors see brain tumours more clearly during scans. It aims to find out if this agent can better identify aggressive brain tumours, especially gliomas, before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are having surgery (biopsy or removal) for a suspected high-grade brain tumour.
- You do not have any medical condition that prevents an MRI with contrast dye.
- You do not have any medical condition that prevents receiving a radioactive tracer.
- You are not pregnant or planning to become pregnant during the study.
- You are not currently enrolled in another drug trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to look for signs of brain tumour activity without needing additional surgery. If you are already having brain surgery, the researchers will compare the MRI images with the tumour tissue to better understand the cancer.
This study checks whether a special scan called PET-MRI can better tell if a child’s brain tumor has come back after treatment. It may help doctors decide faster and more accurately when changes seen on regular MRI are true tumor recurrence.
This trial tests whether using a special PET scan (a type of imaging that shows tumor activity) during brain tumor surgery helps doctors remove more of the tumor safely. You would have a high-grade glioma (an aggressive brain cancer) and be scheduled for surgery.
This study uses a special type of MRI scan combined with PET imaging to look at brain tumors after treatment. It aims to figure out whether new spots seen on MRI are leftover tumor or treatment effects, which could help guide your next care steps.
This trial tests a new imaging tracer that may help doctors see brain tumors (gliomas) more clearly before surgery. It could help guide treatment and is for people scheduled for surgery or biopsy.
This trial tests how well a special PET/MRI scan can help doctors evaluate gliomas and brain metastases. It may help improve diagnosis and treatment planning by comparing scan results with tissue samples or surgery findings.
Hear when a new Glioma, Malignant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.